rxstat › Shortages › Atorvastatin
Atorvastatin shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Atorvastatin products are in shortage in Canada (11 of 64 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 1, 2027.
Products affected
11 of 64
In shortage since
Jun 29, 2016
Est. full return
Jun 1, 2027
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageMYLAN-ATORVASTATIN
20MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02392941 · since Jul 2, 2026, est. end Jul 28, 2026 · Disruption of the manufacture of the drug.
Active shortageACH-ATORVASTATIN CALCIUM
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02457741 · since Mar 22, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortageACH-ATORVASTATIN CALCIUM
40MG · TABLET · ACCORD HEALTHCARE INC
DIN 02457776 · since May 30, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortageACH-ATORVASTATIN CALCIUM
80MG · TABLET · ACCORD HEALTHCARE INC
DIN 02457784 · since May 30, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortageACH-ATORVASTATIN CALCIUM
20MG · TABLET · ACCORD HEALTHCARE INC
DIN 02457768 · since May 30, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortagePMSC-ATORVASTATIN
80MG · TABLET · PHARMASCIENCE INC
DIN 02507269 · since Aug 3, 2025, est. end Jun 1, 2027 · Disruption of the manufacture of the drug.
Active shortagePMSC-ATORVASTATIN
20MG · TABLET · PHARMASCIENCE INC
DIN 02507242 · since Aug 3, 2025, est. end Jun 1, 2027 · Disruption of the manufacture of the drug.
Active shortagePMSC-ATORVASTATIN
10MG · TABLET · PHARMASCIENCE INC
DIN 02507234 · since Aug 3, 2025, est. end Jun 1, 2027 · Disruption of the manufacture of the drug.
Active shortageAPO-ATORVASTATIN
20MG · TABLET · APOTEX INC
DIN 02295288 · since Mar 31, 2026, est. end May 22, 2026 · Disruption of the manufacture of the drug.
Active shortageRATIO-ATORVASTATIN
80MG · TABLET · TEVA CANADA LIMITED
DIN 02350335 · since Apr 1, 2017, no end estimate · Delay in shipping of the drug.
Active shortageRATIO-ATORVASTATIN
40MG · TABLET · TEVA CANADA LIMITED
DIN 02350327 · since Jun 29, 2016, no end estimate · Disruption of the manufacture of the drug.
Active shortageRATIO-ATORVASTATIN
80MG · TABLET · TEVA CANADA LIMITED
DIN 02350335 · since May 17, 2017, no end estimate · Requirements related to complying with good manufacturing practices.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Atorvastatin is currently affected by 11 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, ACCORD HEALTHCARE INC, PHARMASCIENCE INC, APOTEX INC and 1 others.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Atorvastatin is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AA).
Recent changes
Common questions
When will Atorvastatin be back in stock in Canada?
The latest manufacturer estimate is Jun 1, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Atorvastatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All lipid modifying agents, plain shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.